In EDTA tubes, KRAS-mutated ctRNA could only be detected in the platelets (CPPlat_P) (Figure 5) in 3 out of 4 KRAS-mutated metastatic cancer patients (as depicted in Figure 3). This evidence concerns the gene KRAS and metastatic malignant neoplasm.